In a report released today, George Farmer from Scotiabank maintained a Buy rating on Inmune Bio (INMB – Research Report), with a price target ...
To get a sense of who is truly in control of Biomea Fusion, Inc. (NASDAQ:BMEA), it is important to understand the ownership structure of the business. With 51% stake, institutions possess the ...
REDWOOD CITY, Calif., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Biomea Fusion, Inc. (“Biomea” or “Biomea Fusion” or “the Company”) (Nasdaq: BMEA), a clinical ...
After hours: February 11 at 6:49:26 p.m. EST ...
After hours: 7 February at 7:31:36 pm GMT-5 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback